DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CELLULOSE
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CELLULOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOTEMUSTINE
3
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Melanoma; Neoplasms; Uveal Melanoma
DNA cross-linking agent
FOTEMUSTINE
×
Maximum Phase:
3
First Approval:
None
UNII:
GQ7JL9P5I2
Molecule Type:
Small molecule
Molecular Formula:
C9H19ClN3O5P
Molecular Weight:
315.69
AlogP:
2.53
PSA:
97.3
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TARANABANT
3
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder; Urinary Incontinence; Diabetes Mellitus, Type 2; Obesity
Cannabinoid CB1 receptor inverse agonist
TARANABANT
×
Maximum Phase:
3
First Approval:
None
UNII:
X9U622S114
Molecule Type:
Small molecule
Molecular Formula:
C27H25ClF3N3O2
Molecular Weight:
515.96
AlogP:
6.31
PSA:
75.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
M-FLUOROBENZYLGUANIDINE
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
M-FLUOROBENZYLGUANIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C8H10FN3
Molecular Weight:
167.19
AlogP:
0.81
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
BHA
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BHA
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAUROLITHOCHOLIC ACID
3
Small molecule
Investigational
Unknown
Unknown
Asthma; Liver Cirrhosis; Multiple Sclerosis; Amyloid Neuropathies, Familial; Diabetes Mellitus, Type 1; Amyotrophic Lateral Sclerosis; Liver Cirrhosis, Biliary
Unknown
TAUROLITHOCHOLIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H45NO5S
Molecular Weight:
483.72
AlogP:
4.43
PSA:
103.7
HBD:
3.0
HBA:
#RotB:
7.0
Source:
NEPIDERMIN
3
Protein
Investigational
Unknown
Unknown
Adenocarcinoma; Breast Neoplasms; Dry Eye Syndromes; Periodontitis; Psoriasis; Wounds and Injuries; Diabetic Foot; Stomatitis
Unknown
NEPIDERMIN
×
Maximum Phase:
3
First Approval:
None
UNII:
TZK30RF92W
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LECOZOTAN HYDROCHLORIDE
3
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Serotonin 1a (5-HT1a) receptor antagonist
LECOZOTAN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
23EDE20K1X
Molecule Type:
Small molecule
Molecular Formula:
C28H30ClN5O3
Molecular Weight:
520.03
AlogP:
3.58
PSA:
81.93
HBD:
0.0
HBA:
#RotB:
6.0
Source:
VALOCTOCOGENE ROXAPARVOVEC
3
Gene
Investigational
Unknown
Unknown
Hemophilia A; Hemorrhage
Coagulation factor IX exogenous protein
VALOCTOCOGENE ROXAPARVOVEC
×
Maximum Phase:
3
First Approval:
None
UNII:
681K1JDI8M
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PERFLUBUTANE
3
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal; Hypertension, Portal
Diagnostic
PERFLUBUTANE
×
Maximum Phase:
3
First Approval:
None
UNII:
SE4TWR0K2C
Molecule Type:
Small molecule
Molecular Formula:
C4F10
Molecular Weight:
238.02
AlogP:
3.38
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
1.0
Source:
CARBIMAZOLE
3
Small molecule
Investigational
Unknown
Unknown
Thyrotoxicosis; Thyroid Diseases
Thyroid peroxidase inhibitor
CARBIMAZOLE
×
Maximum Phase:
3
First Approval:
None
UNII:
8KQ660G60G
Molecule Type:
Small molecule
Molecular Formula:
C7H10N2O2S
Molecular Weight:
186.24
AlogP:
1.56
PSA:
36.16
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ABICIPAR PEGOL
3
Protein
Investigational
Unknown
Unknown
Wet Macular Degeneration; Macular Edema; Macular Degeneration; Retinal Neovascularization
Vascular endothelial growth factor A inhibitor
ABICIPAR PEGOL
×
Maximum Phase:
3
First Approval:
None
UNII:
M55Q728KNA
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NITRIC ACID
3
Small molecule
Investigational
Unknown
Unknown
Respiratory Insufficiency; Coronary Disease; Heart Failure; Heart Failure, Systolic; Menopause; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pancreatitis; Reperfusion Injury
Unknown
NITRIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
411VRN1TV4
Molecule Type:
Small molecule
Molecular Formula:
HNO3
Molecular Weight:
63.01
AlogP:
-0.35
PSA:
63.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
LANIFIBRANOR
3
Small molecule
Investigational
Unknown
Unknown
Scleroderma, Diffuse; Non-alcoholic Fatty Liver Disease
Peroxisome proliferator-activated receptor agonist
LANIFIBRANOR
×
Maximum Phase:
3
First Approval:
None
UNII:
28Q8AG0PYL
Molecule Type:
Small molecule
Molecular Formula:
C19H15ClN2O4S2
Molecular Weight:
434.93
AlogP:
4.55
PSA:
89.26
HBD:
1.0
HBA:
#RotB:
6.0
Source:
IDRABIOTAPARINUX SODIUM
3
Oligosaccharide
Investigational
Unknown
Unknown
Atrial Fibrillation; Thrombosis; Venous Thrombosis
Coagulation factor X inhibitor
IDRABIOTAPARINUX SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
K2T918I23K
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RHNRG-1
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RHNRG-1
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
URACIL
3
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms
Unknown
URACIL
×
Maximum Phase:
3
First Approval:
None
UNII:
56HH86ZVCT
Molecule Type:
Small molecule
Molecular Formula:
C4H4N2O2
Molecular Weight:
112.09
AlogP:
-0.94
PSA:
65.72
HBD:
2.0
HBA:
#RotB:
0.0
Source:
EPI
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
EPI
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANASCORP
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ANASCORP
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAMPALIZUMAB
3
Antibody
Investigational
Unknown
Unknown
Geographic Atrophy
Complement factor D inhibitor
LAMPALIZUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
UWU93Y99R3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MELPHALAN FLUFENAMIDE HYDROCHLORIDE
3
Small molecule
Investigational
Unknown
Unknown
Amyloidosis, Familial; Multiple Myeloma
DNA cross-linking agent
MELPHALAN FLUFENAMIDE HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
3412470A0V
Molecule Type:
Small molecule
Molecular Formula:
C24H31Cl3FN3O3
Molecular Weight:
534.89
AlogP:
3.27
PSA:
84.66
HBD:
2.0
HBA:
#RotB:
13.0
Source:
TOLEBRUTINIB
3
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
Tyrosine-protein kinase BTK inhibitor
TOLEBRUTINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
8CZ82ZYY9X
Molecule Type:
Small molecule
Molecular Formula:
C26H25N5O3
Molecular Weight:
455.52
AlogP:
3.91
PSA:
95.38
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BENEGRASTIM
3
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
BENEGRASTIM
×
Maximum Phase:
3
First Approval:
None
UNII:
5UPW5HJW3O
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LISURIDE
3
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Parkinson Disease; Restless Legs Syndrome; Migraine Disorders
Unknown
LISURIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
E0QN3D755O
Molecule Type:
Small molecule
Molecular Formula:
C20H26N4O
Molecular Weight:
338.46
AlogP:
2.84
PSA:
51.37
HBD:
2.0
HBA:
#RotB:
3.0
Source:
APLAVIROC HYDROCHLORIDE
3
Small molecule
Investigational
Unknown
Unknown
HIV Infections
C-C chemokine receptor type 5 antagonist
APLAVIROC HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
04D148Z3VR
Molecule Type:
Small molecule
Molecular Formula:
C33H44ClN3O6
Molecular Weight:
614.18
AlogP:
4.58
PSA:
119.41
HBD:
3.0
HBA:
#RotB:
10.0
Source:
HIBERIX
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HIBERIX
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPARTYL-ALANYL-DIKETOPIPERAZINE
3
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome; Osteoarthritis, Knee
Immunomodulation
ASPARTYL-ALANYL-DIKETOPIPERAZINE
×
Maximum Phase:
3
First Approval:
None
UNII:
R9CHM391D5
Molecule Type:
Small molecule
Molecular Formula:
C7H10N2O4
Molecular Weight:
186.17
AlogP:
-1.54
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
2.0
Source:
PEMTUMOMAB
3
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 binding agent
PEMTUMOMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLATELET CONCENTRATE
3
Unknown
Investigational
Unknown
Unknown
Aortic Dissection; Hematologic Neoplasms; Purpura, Thrombocytopenic, Idiopathic
Unknown
PLATELET CONCENTRATE
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TARIBAVIRIN HYDROCHLORIDE
3
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
TARIBAVIRIN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
D22JZE246P
Molecule Type:
Small molecule
Molecular Formula:
C8H14ClN5O4
Molecular Weight:
279.68
AlogP:
-2.83
PSA:
150.5
HBD:
5.0
HBA:
#RotB:
3.0
Source:
GTX-024
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GTX-024
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLYGLACTIN 910
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
POLYGLACTIN 910
×
Maximum Phase:
3
First Approval:
None
UNII:
51L8Z461QZ
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TANNIC ACID
3
Unknown
Investigational
Unknown
Unknown
Gastroenteritis
Unknown
TANNIC ACID
×
Maximum Phase:
3
First Approval:
None
UNII:
28F9E0DJY6
Molecule Type:
Unknown
Molecular Formula:
C76H52O46
Molecular Weight:
1701.21
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PYRROLE
3
Small molecule
Investigational
Unknown
Unknown
Aspergillosis
Unknown
PYRROLE
×
Maximum Phase:
3
First Approval:
None
UNII:
86S1ZD6L2C
Molecule Type:
Small molecule
Molecular Formula:
C4H5N
Molecular Weight:
67.09
AlogP:
1.01
PSA:
15.79
HBD:
1.0
HBA:
#RotB:
0.0
Source:
FINOTONLIMAB
3
Antibody
Investigational
Unknown
Unknown
Lymphoma; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell
Programmed cell death protein 1 inhibitor
FINOTONLIMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
533Z4G2286
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
236
237
238
239
240
241
242
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA